AstraZeneca is beating the odds this week. The COVID-19 vaccination is still controversial, but it doesn’t stop the company’s stock price rising. With the 1.3% increase today, the share price has recently surged over 8% within only five days, building on the enthusiasm from the strong Q1 results announced last …
Read More »AstraZeneca Vaccine Booster Works Against Omicron
A three-dose course of AstraZeneca’s COVID-19 vaccine is effective against the rapidly-spreading Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford University lab study. The study, which has not yet been published in a medical journal, showed that levels of omicron antibodies after receiving the …
Read More »Oxford and AstraZeneca developing Omicron-targeted version of vaccine
Oxford University and AstraZeneca have begun work on an Omicron-targeted version of their coronavirus vaccine, joining the ranks of their peers who are studying the potential for adapting formulations of their shots in case they become necessary to tackle the variant. When asked about Omicron, Sandy Douglas, a research group …
Read More »A new drug from AstraZeneca against Corona passes the last stage of trials
AstraZeneca Inc said on Monday that its antibody-mixture drug, the first protective dose other than vaccines against Covid-19, has achieved its main goals in last-stage trials by helping reduce severe cases of Covid-19 infection or death
Read More »India Records Highest Daily Death Toll in a Month due to Covid-19
India’s health ministry data showed that the country recorded 4,2015 new coronavirus cases in the last 24 hours, while the number of deaths jumped by 3,998, the highest daily toll since June 12. The data revealed that the total number of injuries reached 31.22 million cases, while the deaths amounted …
Read More »Britain: Talks With AstraZeneca About The Vaccine to Combat Beta COVID-19 Variant
British Health Minister Matt Hancock said Wednesday, June 2 that his country is in talks with Oxford and AstraZeneca to obtain additional doses of their vaccine against the Corona virus, which has been modified to better target the (beta) strain of the emerging corona virus that first appeared in South …
Read More »Canadian Province of Alberta Confirms First Death Related to AstraZeneca Vaccine – Reuters
The head of the medical sector in the Canadian province of Alberta said in a statement that the province witnessed the first death related to the AstraZeneca vaccine against Covid-19 disease. Late on Tuesday, he said that a woman in her 50s had died after being injected with the vaccine. …
Read More »AstraZeneca Reports Earnings Per Share of $1.19 in Q1 2021, up 100% Year-on-Year
AstraZeneca reported a 100% year-on-year increase in earnings per share for Q1 of 2021, to $1.19. The company achieved strong revenue growth of 15% in Q1 of 2021 to $7.3 billion, excluding a contribution from the pandemic vaccine COVID-19, revenue growth increased by 11% to $7.04 billion.
Read More »European Union v. AstraZeneca Case Begins in Brussels
A court in Brussels has begun hearing a lawsuit filed by the European Commission against the pharmaceutical company AstraZeneca over supplies of its Covid-19 vaccine, as the cartel’s lawyers are pressing for immediate delivery of doses from all factories, including those in Britain. The case is the latest turning point …
Read More »AstraZeneca Will Have 200 Million Doses of COVID-19 Vaccine by The End of The Year
Pam Cheng, chief operating officer at AstraZeneca, said that the company will have 200 million doses of its candidate vaccine, which it developed in cooperation with the University of Oxford, by the end of 2020, and that 700 million doses will be ready worldwide by the end of Q1 of …
Read More »